Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

the ECHELON-1 Study Group

Research output: Contribution to journalArticlepeer-review

151 Scopus citations

Fingerprint

Dive into the research topics of 'Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology